United States Diagnostics & Research news

21:13 10 Aug 2026

Stock Titan Market update Main company 🇺🇸 United States

ADPT (ADPT) insider outlines Form 144 sale of 3,000 shares

A holder of Adaptive Biotechnologies Corp (ADPT) common stock has filed a Form 144, indicating an intention to sell 3,000 shares valued at $74,790.00 through Morgan Stanley Smith Barney. These shares are Restricted Stock Units acquired from the issuer on March 4, 2023. The …

ADPT main company

Sharemaestro market context Trend signal active 52 weeks +91.2% · Next-week setup positive 56.1%

21:09 10 Aug 2026

The Manila Times Earnings Main company 🇺🇸 United States

IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx

Insight Molecular Diagnostics Inc. (IMDX) reported its Q2 2026 results and provided an update on the FDA review of its GraftAssureDx product. The company is progressing with the FDA, expecting marketing authorization soon, and highlighted favorable Medicare reimbursement policy changes. IMDX also shared clinical …

IMDX main company

Sharemaestro market context Price below Trend Line 52 weeks +101.3% · Next-week setup negative 43.4%

21:05 10 Aug 2026

finance.yahoo.com Market update Main company 🇺🇸 United States

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PALO ALTO, Calif., August 10, 2026--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on July 21, 2026, the Compensation Committee of Guardant's Board of Directors approved the granting of restricted stock units ("RSUs") representing 46,044 shares of its …

GH main company

Sharemaestro market context Trend signal active 52 weeks +186.1%

21:05 10 Aug 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel

QIAstat-Dx BCID GPF Plus AMR Panel detects 20 pathogen targets and 10 antimicrobial resistance markers from positive blood cultures in about one hour FDA clearance marks QIAGEN's entry into U.S. bloodstream infection testing and establishes the first member of a planned QIAstat-Dx BCID panel …

QGEN main company

Sharemaestro market context Price above Trend Line 52 weeks -14.7%

20:58 10 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇺🇸 United States

Sector Update: Healthcare Stocks Gain Late Afternoon

Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 1% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.4%.The iShares Biotechnology ETF (IBB) climbed 1%.In corporate news, Eli Lilly (LLY) received UK authorization for Silver Upgrade …

TMO mentioned

Sharemaestro market context Price above Trend Line 52 weeks +21.9%

20:44 10 Aug 2026

GlobeNewswire Earnings Provider-linked mention 🇺🇸 United States

Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Alpha Tau Medical Ltd. reported its second-quarter 2026 financial results, highlighting significant clinical and corporate achievements. These include positive interim results from the REGAIN trial for recurrent glioblastoma, a strategic collaboration with Tolmar for prostate cancer, and the completion of patient enrollment for the …

LH mentioned

Sharemaestro market context Trend signal active 52 weeks +19.3%

20:41 10 Aug 2026

TradingView Market update Main company 🇺🇸 United States

PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG

QIAGEN N.V. has released a voting rights announcement in accordance with Article 40, Section 1 of the WpHG, following a notification from the AFM on August 7, 2026. The announcement details Goldman Sachs Group Inc.'s holdings in QIAGEN N.V., including various types of shares …

QGEN main company

Sharemaestro market context Price above Trend Line 52 weeks -14.7%

20:40 10 Aug 2026

MarketBeat Earnings Main company 🇺🇸 United States

HC Wainwright Forecasts Biodesix's Q3 Earnings (NASDAQ:BDSX)

HC Wainwright has updated its Q3 2026 EPS estimates for Biodesix (NASDAQ:BDSX), lowering it to a loss of $0.75 per share, while maintaining a "Buy" rating and a $27 price target. This follows Biodesix's recent Q2 earnings report where the company surpassed analyst expectations, …

BDSX main company

Sharemaestro market context Trend signal active 52 weeks +196.5% · Next-week setup negative 42.9%

20:15 10 Aug 2026

finance.yahoo.com Regulatory and legal Main company 🇺🇸 United States

How Investors Are Reacting To Thermo Fisher Scientific (TMO) New FDA-Cleared Multiple Myeloma Platform

In late July 2026, Thermo Fisher Scientific used the ADLM conference in Anaheim to highlight new FDA-cleared diagnostic platforms, including the EXENT Solution for multiple myeloma and EliA CTD 13 Screen for systemic autoimmune connective tissue diseases, alongside expanded digital and quality-control offerings for …

TMO main company

Sharemaestro market context Price above Trend Line 52 weeks +21.9%

20:13 10 Aug 2026

Stock Traders Daily Market update Main company 🇺🇸 United States

How Guardant Health Inc. (GH) Affects Rotational Strategy Timing

This article analyzes Guardant Health Inc. (GH) using AI models to provide trading strategies and signal analysis. It indicates strong sentiment for GH across all horizons, supporting an overweight bias, and outlines specific position, momentum, and risk-hedging strategies with entry zones, targets, and stop …

GH main company

Sharemaestro market context Trend signal active 52 weeks +186.1%

19:37 10 Aug 2026

GuruFocus Earnings Main company 🇺🇸 United States

Saraza Management, LP's Danaher Corp(DHR) Holding History

This article details Saraza Management, LP's historical holdings in Danaher Corp (DHR). As of March 31, 2026, Saraza Management held no shares of DHR, following previous purchases and sales. The estimated gain on their past DHR holdings is reported as a loss of $371,695.00, …

DHR main company

Sharemaestro market context Price above Trend Line 52 weeks -2.2%

19:21 10 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇺🇸 United States

1 Surging Stock with Competitive Advantages and 2 We Turn Down

1 Surging Stock with Competitive Advantages and 2 We Turn Down The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance. But not every …

WAT mentioned

Sharemaestro market context Trend signal active 52 weeks +39.6%

19:11 10 Aug 2026

TradingKey Earnings Main company 🇺🇸 United States

MDxHealth SA (MDXH) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for MDxHealth SA (MDXH), indicating a current earnings forecast score of 7.67, ranking 275th in its industry. Analysts have set an average price target of $7.00, with most recommending a "Buy" trend. The company's expected revenue for the …

MDXH main company

Sharemaestro market context Price below Trend Line 52 weeks -83.8% · Next-week setup negative 38.1%

18:51 10 Aug 2026

Clinical Lab Products Earnings Main company 🇺🇸 United States

Revvity Launches SuperFlex Prenatal Screening System for Preeclampsia

Revvity has introduced the SuperFlex prenatal screening system, a compact immunoassay instrument designed for small to mid-sized laboratories and clinics to offer preeclampsia testing and biochemical screening. This CE-IVDR certified system aims to lower financial and operational barriers to in-house prenatal screening, providing access …

RVTY main company

Sharemaestro market context Trend signal active 52 weeks +26.6%

18:40 10 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇺🇸 United States

Sector Update: Healthcare Stocks Rise in Afternoon Trading

Healthcare stocks were higher Monday afternoon, with the NYSE Healthcare Index up 0.9% and the State PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already …

TMO mentioned

Sharemaestro market context Price above Trend Line 52 weeks +21.9%

18:28 10 Aug 2026

nasdaq.com Market update Provider-linked mention 🇺🇸 United States

Stocks Mixed as Higher Crude Prices Boost T-Note Yields

The S&P 500 Index ($SPX) (SPY) today is up +0.05%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.02%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.15%. September E-mini S&P futures (ESU26) are up +0.03%, and September E-mini Nasdaq futures (NQU26) …

RDNT mentioned

Sharemaestro market context Price above Trend Line 52 weeks +7.3%

17:47 10 Aug 2026

StocksToTrade Earnings Main company 🇺🇸 United States

Twist Bioscience TWST Jumps As Guidance, Targets And Cash Raise Align

Twist Bioscience (TWST) saw its stock jump after exceeding Q3 revenue expectations, raising its full-year 2026 guidance, and targeting adjusted EBITDA breakeven in Q4. Analyst firms like TD Cowen, Piper Sandler, and Baird increased their price targets to $115, citing strong demand from AI-enabled …

TWST main company

Sharemaestro market context Trend signal active 52 weeks +311.3%

17:41 10 Aug 2026

Investing.com Earnings Main company 🇺🇸 United States

Earnings call transcript: RadNet tops Q2 2026 estimates, shares rise 6.1%

RadNet reported stronger-than-expected Q2 2026 results, with adjusted EPS of $0.29 and revenue of $622.7 million, exceeding analyst estimates. The company saw record total revenue and adjusted EBITDA, driven by growth in advanced imaging and digital health. Shares rose 6.09% in after-hours trading, and …

RDNT main company

Sharemaestro market context Price above Trend Line 52 weeks +7.3%

17:40 10 Aug 2026

TIKR.com Guidance Main company 🇺🇸 United States

Illumina Stock Is Up 40% Since January. Should You Still Ride the Wave in 2026?

Illumina stock (ILMN) has rallied 40% since January, reaching a 52-week high of $204 before settling at $188, driven by strong Q2 results and raised guidance, particularly in its clinical sequencing business. Wall Street analysts are now playing catch-up, revising their price targets upward, …

ILMN main company

Sharemaestro market context Trend signal active 52 weeks +87.8%

17:22 10 Aug 2026

Medical Product Outsourcing Market update Main company 🇺🇸 United States

bioAffinity Technologies to Add Mexican Patent to its CyPath Lung Technology IP

bioAffinity Technologies Inc. has received notification of patent allowance in Mexico for its CyPath Lung technology, further strengthening its global intellectual property portfolio. This patent protects the use of flow cytometry and specific labeling methods for detecting lung cancer cells in sputum, expanding on …

BIAF main company

Sharemaestro market context Price below Trend Line 52 weeks -92.7% · Next-week setup negative 40.0%

17:02 10 Aug 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Sotera Health Company (SHC) Reported Positive Results Amid Litigation Wins

US-based investment company McIntyre Partnerships delivered flat performance in H1 2026, returning 0% gross and -1% net compared to the Russell 2000 Value Index's 23% return. A copy of the letter can be downloaded here. The second quarter results were a complete reversal of …

SHC main company

Sharemaestro market context Trend signal started 52 weeks +19.8%

17:02 10 Aug 2026

nasdaq.com Market update Provider-linked mention 🇺🇸 United States

Stocks Pressured as Higher Crude Price Boosts T-Note Yields

The S&P 500 Index ($SPX) (SPY) today is down -0.04%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.14%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.15%. September E-mini S&P futures (ESU26) are down -0.04%, and September E-mini Nasdaq futures (NQU26) …

RDNT mentioned

Sharemaestro market context Price above Trend Line 52 weeks +7.3%

16:40 10 Aug 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

CON or MEDP: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical Services sector have probably already heard of Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. Everyone has their own …

MEDP main company

Sharemaestro market context Trend signal started 52 weeks +29.0%

16:38 10 Aug 2026

The Globe and Mail Earnings Provider-linked mention 🇺🇸 United States

Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich?

Labcorp (LH) is showing improved revenue growth, wider margins, and higher full-year guidance, particularly in specialty testing and biopharma services. However, its current valuation is considered rich, trading at a premium to its historical median and sub-industry multiple, which raises the bar for future …

DGX mentioned LH mentioned MEDP mentioned

Sharemaestro market context Trend signal active 52 weeks +34.3% · Next-week setup positive 57.4%

16:01 10 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇺🇸 United States

3 Growth Stocks with All-Star Potential

3 Growth Stocks with All-Star Potential Growth boosts valuation multiples, but it doesn't always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022. The …

NTRA mentioned

Sharemaestro market context Trend signal active 52 weeks +97.6% · Next-week setup positive 58.3%

15:41 10 Aug 2026

AlphaStreet Earnings Main company 🇺🇸 United States

RadNet Jumps 8.2% on EPS Beat

RadNet shares surged 8.2% after the diagnostic imaging provider reported strong second-quarter earnings. The company posted an EPS of $0.29 on revenue of $622.7 million for the quarter ended June 2026, boosting its market capitalization to $6.0 billion. Investors will be watching if RadNet …

RDNT main company

Sharemaestro market context Price above Trend Line 52 weeks +7.3%

15:39 10 Aug 2026

Yahoo! Finance Canada Earnings Main company 🇺🇸 United States

Revvity, Inc. (RVTY) Stock Forecasts

Morningstar analyst Julie Utterback published a report on Revvity, Inc. (RVTY), a global life sciences and diagnostics company. The report, titled "Revvity Earnings: Strong but Dressed-Up Quarter Boosts 2026 Outlook," was released on August 4, 2026. Revvity operates in life sciences and signals software …

RVTY main company

Sharemaestro market context Trend signal active 52 weeks +26.6%

15:10 10 Aug 2026

PR Newswire Regulatory and legal Main company 🇺🇸 United States

Myriad Genetics (MYGN) Securities Investigation Notice - Levi & Korsinsky

Levi & Korsinsky is investigating Myriad Genetics (MYGN) for potential securities law violations after the company reported lower-than-expected Q2 2026 revenue, cut its full-year revenue guidance, and suspended adjusted EBITDA guidance. The investigation focuses on whether Myriad Genetics made materially false or misleading statements …

MYGN main company

Sharemaestro market context Price below Trend Line 52 weeks -42.9%

14:47 10 Aug 2026

Clinical Lab Products Regulatory and legal Provider-linked mention 🇺🇸 United States

FDA Advisory Committee to Review GRAIL Multi-Cancer Early Detection Test

The FDA's Molecular and Clinical Genetics Panel will meet on September 23, 2026, to review GRAIL's Premarket Approval application for the Galleri multi-cancer early detection blood test. This test aims to identify cancer-specific methylation patterns before symptoms appear, including for cancers currently without recommended …

DGX mentioned

Sharemaestro market context Trend signal active 52 weeks +34.3% · Next-week setup positive 57.4%

14:40 10 Aug 2026

Simply Wall Street Earnings Main company 🇺🇸 United States

Guardant Health (GH) Is Up 6.1% After Raising 2026 Revenue Outlook And Filing Shelf Registration - Has The Bull Case Changed?

Guardant Health (GH) saw its stock rise 6.1% after increasing its 2026 revenue guidance to US$1.34–1.36 billion, driven by accelerated Shield screening adoption and new UnitedHealth coverage. While the raised outlook strengthens the bull case for sales growth, the company also filed a shelf …

GH main company DGX mentioned LH mentioned

Sharemaestro market context Trend signal active 52 weeks +186.1%

14:22 10 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇺🇸 United States

PODD's Q2 Earnings Top Estimates, FY'26 Sales View Cut, Stock Down

Insulet Corporation PODD reported second-quarter 2026 adjusted earnings per share (EPS) of $1.66, up 41.5% year over year. The bottom line beat the Zacks Consensus Estimate by 15.28%. GAAP EPS came in at $1.37 compared with the year-ago quarter's figure of 32 cents. Revenues …

DGX mentioned LH mentioned MEDP mentioned

Sharemaestro market context Trend signal active 52 weeks +34.3% · Next-week setup positive 57.4%

14:15 10 Aug 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Understanding Qiagen (QGEN) Reliance on International Revenue

Have you assessed how the international operations of Qiagen (QGEN) performed in the quarter ended June 2026? For this diagnostic products maker, possessing an expansive global footprint, parsing the trends of international revenues could be critical to gauge its financial resilience and growth prospects. …

QGEN main company

Sharemaestro market context Price above Trend Line 52 weeks -14.7%

14:10 10 Aug 2026

Pluang Regulatory and legal Main company 🇺🇸 United States

Medpace Holdings faces lawsuit over alleged misleading growth info causing inflated stock prices.

Medpace Holdings Inc. is being investigated by Kuehn Law for allegedly misleading shareholders with misrepresented business metrics, including backlog cancellations and growth projections. The lawsuit claims these overly optimistic expectations led investors to purchase stock at inflated prices. Shareholders who bought stock before April …

MEDP main company

Sharemaestro market context Trend signal started 52 weeks +29.0%

14:10 10 Aug 2026

Morningstar Regulatory and legal Main company 🇺🇸 United States

Kuehn Law Encourages Investors of Medpace Holdings, Inc. to Contact Law Firm

Kuehn Law, PLLC is investigating Medpace Holdings, Inc. (NASDAQ: MEDP) for potential breaches of fiduciary duties by its officers and directors. A federal securities lawsuit alleges that Medpace misrepresented its backlog cancellation rates, business conditions, and ability to maintain its projected 1.15 book-to-bill ratio, …

MEDP main company

Sharemaestro market context Trend signal started 52 weeks +29.0%

13:49 10 Aug 2026

seekingalpha.com Market update Provider-linked mention 🇺🇸 United States

High-flyer healthcare stocks: Ten names with strong momentum, weak valuations

[Heart Health Concept] Eoneren/E+ via Getty Images Wall Street investors are increasingly seeking refuge in high-performing equity plays as volatile healthcare markets continue to shift, forcing a critical evaluation of stock price velocity against fundamental underlying valuations. Analysts warn that chasing recent momentum can …

CDNA mentioned

Sharemaestro market context Trend signal active 52 weeks +294.3%

13:40 10 Aug 2026

GuruFocus Analyst action Main company 🇺🇸 United States

BDSX Maintained by Canaccord Genuity -- Price Target Raised to $35

Canaccord Genuity has maintained a 'Buy' rating for Biodesix (BDSX) and increased its price target from $27.00 to $35.00, indicating strong confidence in the company's future. While analysts are optimistic about Biodesix's growth, particularly in medical diagnostics, the stock is considered modestly overvalued according …

BDSX main company

Sharemaestro market context Trend signal active 52 weeks +196.5% · Next-week setup negative 42.9%